The GLUCARE consortium, which Safe Implant Technology is part of, has been awarded with funding from EUROSTARS to execute the ~€1,3M GLUCARE project aiming to develop a first-in-class implantable biosensor for continuous glucose monitoring (CGM) with long-term tolerability that will allow diabetic patients to benefit from accurate real-time blood glucose measurements for more effective diabetes management.